Keyphrases
Subunit Vaccine
100%
Cross-protection
100%
Burkholderia Pseudomallei
100%
Pseudomallei
100%
Glycoconjugate Vaccines
100%
Burkholderia Cepacia Complex
100%
Complex Species
57%
Burkholderia
28%
Etiological Agents
14%
Vaccine Development
14%
Gram-negative Bacteria
14%
Clinically Significant
14%
Cystic Fibrosis
14%
Cause of Disease
14%
Protective Efficacy
14%
Efficacy Study
14%
High-risk Population
14%
Heterologous Protein
14%
Glanders
14%
Melioidosis
14%
Sequence Conservation
14%
Protection Mechanism
14%
Complex Sequences
14%
Malleus
14%
Amino Acid Sequence Conservation
14%
Burkholderia Species
14%
Subunit Antigen
14%
Opportunistic Bacteria
14%
Immunology and Microbiology
Cross Protection
100%
Burkholderia pseudomallei
100%
Glycoconjugate
100%
Burkholderia Cepacia Complex
100%
Immunology
80%
Burkholderia
60%
Gram-Negative Bacteria
20%
Amino Acid Sequence
20%
Population Risk
20%
Pharmacology, Toxicology and Pharmaceutical Science
Glycoconjugate
100%
Burkholderia pseudomallei
100%
Burkholderia Cepacia Complex
100%
Burkholderia
60%
Disease
40%
Amino Acid
20%
Gram Negative Bacterium
20%
Efficacy Study
20%
Cystic Fibrosis
20%
Glanders
20%
Melioidosis
20%